4 minute read
Oct. 29, 2022
Vadadustat: an Oral Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Domain (HIF-PHD) Inhibitor
vadadustat
oral HIF-PHD enzyme inhibitor Ph. III candidate for anemia in CKD carboxylic acid class of HIF-PHD inhibitors J. Pharmacol. Exp. Ther., Oct 1, 2022 Akebia Therapeutics, Cambridge, MA